1. Treatment advances in adult immune thrombocytopenic purpura

   • M. R. Huber
   • S. Kumar
   • A. Tefferi

   Review Article 12 September 2003 Pages: 723 - 737

   

2. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias

   • C. S. Chim
   • A. S. Y. Wong
   • Y. L. Kwong

   Original Article 25 September 2003 Pages: 738 - 742

   

3. Dynamics of circulating t(14;18)-positive cells during first-line and subsequent lines of treatment in follicular lymphoma

   • C. M. P. W. Mandigers
   • J. P. P. Meijerink
   • J. M. M. Raemaekers

   Original Article 25 September 2003 Pages: 743 - 749

   

4. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses

   • M. J. Peñarrubia
   • J. Odriozola
   • Spanish Group on IFN and CML

   Original Article 27 September 2003 Pages: 750 - 758

   

5. High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities

   • Patrick D. Thornton
   • Estella Matutes
   • Daniel Catovsky

   Original Article 10 October 2003 Pages: 759 - 765

6. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody

   • Dany Gholam
   • Jean-Marie Vantelon
   • Jean-Henri Bourhis

   Case Report 30 July 2003 Pages: 766 - 768

7. Hereditary spherocytosis associated with mutations in HFE gene

   • M. A. Montes-Cano
   • F. Rodríguez-Muñoz
   • M. F. González-Escribano

   Case Report 05 September 2003 Pages: 769 - 772

   

8. Autoimmune hemolytic anemia as a first manifestation of primary effusion lymphoma

   • H. Chiba
   • T. Matsunaga
   • Y. Niitsu

   Case Report 27 September 2003 Pages: 773 - 776